45 results about "Vaginal insert" patented technology

Disclosed herein is, among other things, a soft gel vaginal pharmaceutical composition and dosage form containing solubilized estradiol for the treatment of vulvovaginal atrophy (VVA) and female sexual dysfunction (FSD).

The invention is a simple surgical drape system for female urology procedures that provides sealed isolation of top versus bottom sides of the drape and only exposes the female urethral meatus area for the procedure. It is achieved by a combination of a drape with a fenestration, a labia spreader where the drape fenestration is attached to provide a seal, and local illumination of the meatus area integrated in the drape system for safer and easier instrument insertion. The labia spreader also frees up one of the operator's hands and provides protection for false catherization. The labia spreader can have a vaginal inserted portion for precise position fixation of the drape fenestration to the female. The drape system also provides improved liquid management made possible by the unique combination of drape and labia spreader acting as seal between the two sides of the drape.

A vaginal insert formed from a composition that, prior to introduction to the vagina, has the physical properties of a liquid, semi-soft gel, paste, foam, or viscous material so that it can be effectively delivered to the vaginal canal. After introduction into the vagina, the composition will expand and / or solidify into a semi-solid or solid structure to substantially fill the entire “H” shaped space of the vagina and a portion of the rugal folds along the length of the vaginal canal. Upon solidifying, the composition defines an insert that, in one embodiment, is suitable for use as a tampon and, in another embodiment, is suitable for use as an incontinence device.

According to various embodiments of this disclosure, pharmaceutical compositions comprising solubilized estradiol are provided. In various embodiments, such compositions are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy.

A method for better isolating and removing a large mass of excised tissue from a female patient's abdominal cavity during a laparoscopic surgery includes the steps of: (1) vaginally inserting a collection bag that includes: (a) a flexible and resilient ring adapted to enable: the ring to be distorted for vaginal insertion, a specified ring open area sized to allow the mass of tissue to pass through it, and the ring to be removed from the patient's abdominal cavity through a laparoscopic-surgery-appropriately-sized incision, (b) a sleeve having a flexible wall and open end that is affixed to the ring and a defined interior volume sized so as to allow the mass of tissue to reside in the sleeve, and (2) utilizing the collection bag to contain the mass of tissue.

A vaginal insert which can be provided in an applicator for the treatment of urinary incontinence in females. The vaginal insert can provide tension-free incontinence treating support perpendicularly to the urethra (i.e., across the urethra).

A vaginal insert controls pH within a human vagina by use of various probiotics which include lactobacillus reuteri, lactobacillus rhamnosus, lactobacillus casei, lactobacillus plantarum, lactobacillus acidophilus, lactobacillus brevis, bifidobacterium lactis, bifidobacterium longum, lactobacillus paracasei, lactobacillus salivarius, and lactobacillus bulgaricus. In other embodiments, the use of aloe vera and aloe vera based derivatives are disclosed. Such derivatives include stabilized high molecular weight aloe vera gel polysaccharides (AVP), purified polysaccharide fractions, aloe succotrina, and aloe vera polysaccharide of Dalton weights in the range of 100,000 to 7 million. The disclosed embodiments may be applied or inserted in the form of gels, tablets, powders and other modalities.

An apparatus for pelvic floor muscle trigger point therapy is disclosed. The apparatus comprises a wand to facilitate the release of one or more trigger points in a pelvic floor muscle of a patient. The wand comprises a central portion extending between a first end and a second end. The central portion includes a first bend and a second bend wherein the first bend is formed between a first end region and a first central region. The second bend is formed between the first central region and a second central region. The first end is configured to be vaginally insertable while the second end configured to be rectally insertable. A power source in electrical communication with one or more switches to selectively control a vibration element during use.

The invention provides a rabbit non-operative embryo transfer instrument, a method and an application thereof. The transfer instrument comprises an outer tube sleeve, an outer tube, an inner tube anda syringe. The rabbit embryo was inserted into the inner tube. Binding recipient rabbit, inserting an outer tube with an outer tube sleeve from the recipient rabbit's vagina until the tip of the outertube reaches the cervix of uterus; Pull out the outer sleeve outward so that the closed end of the outer sleeve is pierced by the tip of the outer sleeve. The outer tube is pushed so that the tip ofthe outer tube passes through the cervix, the inner tube is inserted into the tip of the outer tube, and the rabbit embryo in the inner tube is injected into the uterus with a syringe connected with the inner tube. The invention eliminates the injury and infection risk of the recipient rabbit caused by the operation, can quickly transfer the rabbit embryo into the recipient rabbit uterus, can improve the efficiency of the rabbit embryo transfer and the fetal birth rate, and is widely applied.

According to various embodiments of this disclosure, pharmaceutical compositions comprising solubilized estradiol are provided. In various embodiments, such compositions are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy.

Generally, a vaginal insert device used to treat urinary incontinence is disclosed. The vaginal insert device includes a support portion, a stabilizing portion, a removal device, and at least one fluid passageway extending though the support portion. The substantially cylindrical support portion has a distal end and a proximal end. In addition, the support portion has a plurality of foldable areas extending from the distal end to the proximal end. Desirably, the plurality of foldable areas helically curve as the plurality of foldable areas extend from the distal end to the proximal end. The largest outer circumference of the support portion has an insertion diameter when the plurality of foldable areas are compressed and foldable inward and an in-use diameter wherein the plurality of foldable areas are extended outward into a maximum in-use diameter position. Desirably, the in-use diameter is larger than the insertion diameter.

The invention discloses a uterine cavity medicine perfusion device. The technical scheme of the device includes a medicine supply mechanism and an inflation mechanism, the medicine supply mechanism is connected with a catheter, the catheter is connected with an insertion tube for inserting into the uterine cavity, and the insertion tube includes an insertion tube. The head and the tube body, the front end of the tube body is provided with a ring groove, and the front end is detachably connected with the insertion head, the ring groove is fixedly connected with an annular first airbag, the first airbag is connected with an inflation tube, and the inflation mechanism is connected with the inflation tube. The invention has the following beneficial effects: when in use, the medical staff inserts the insertion tube into the uterine cavity through the vagina, the inflation mechanism inflates the first airbag through the inflation tube, so that the first airbag inflates, thereby sealing the uterine cavity, and the medicine supply mechanism The medicinal liquid is introduced into the uterine cavity through the catheter and the insertion tube, so that the medicine is not easy to flow out of the uterine cavity, so as to ensure that the medicine plays a sufficient role and improve the curative effect.

A method of making a vaginal insert. The vaginal insert can have a core, a cover and a removal element. In various embodiments, the covering may conform to the vaginal insert.

A vaginal insert which can be provided in an applicator for the treatment of urinary incontinence in females. The vaginal insert can provide tension-free incontinence treating support perpendicularly to the urethra (i.e., across the urethra).